Rhythm Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: RYTM
Share price (7/21/26): $106.60
Market cap (7/21/26): $7.306 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 10-K 84 pages Share Purchase Agreement by and Among Rhythm Pharmaceuticals Netherlands B.V., the Sellers Listed on the Signature Page Hereto, Xinvento B.V. and the Seller Representative Identified Herein Dated as of February 24, 2023

from 8-K 27 pages Asset Purchase Agreement by and Between Alexion Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. January 5, 2021 Asset Purchase Agreement